$ALPS News

Why Did Alps Group (ALPS) Stock Jump Over 15% After Hours?

Reported Earlier: Alps Group Rolling Out Internal Patient-Derived Organoid Program For Personalized Cancer Treatment In Partnership With Dr. Kong Wai Mun Of Axiocell Biotech

Alps Group Inc Launches Patient-Derived Organoid Program to Advance Personalized Cancer Care in Southeast Asia

Alps Group Inc Expands MyGenome Accreditation to Include Whole Genome Sequencing Under MS ISO 15189:2022

ALPS Group Subsidiary MyGenome Sdn Bhd Receives Accreditation For Whole Genome Sequencing Under MS ISO 15189:2022 Clinical Standards

Alps Group Inc Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Alps Group Receives Non‑Compliance Notice From Nasdaq

Alps Group Appoints Former Ernst & Young Partner to Board of Directors, Strengthening Governance and Capital Markets Oversight

Alps Group Inc Publishes Clinical Safety, Tolerability and Effectiveness Data Supporting Advancement of Its Autologous NK Cell Pipeline Using an In-House Developed Culture Protocol

Alps Group Inc Announces Potential Pipeline Expansion Beyond CELESOME(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome Therapy

Alps Group Expands Its Exosome-Related Pipeline Beyond Its Previously Disclosed CELESOME(+) Program

Alps Group Inc Appoints Cheing Lye-Ping as Chief Financial Officer

Alps Group Appoints Cheing Lye-Ping CFO, Effective Jan. 5

Alps Group Inc (NASDAQ:ALPS) CEO Seng Tham's holdings dropped 12% in value as a result of the recent pullback

Alps Announces Closing of Business Combination with Globalink Investment Inc.